Sanofi Boasts a Dividend Yield of 5.4%, Trades Below 9x Earnings, and Just Got an FDA Win. Are Income Investors Missing a Rare Opportunity?

Summary

Sanofi recently received an FDA approval win and trades at a 5.4% dividend yield with a valuation below 9x earnings, presenting a potential opportunity for income-focused investors.